Biosynthesis of cholesterol

Synthesis within the body starts with the mevalonate pathway where two molecules of acetyl CoA condense to form acetoacetyl-CoA. This is followed by a second condensation between acetyl CoA and acetoacetyl-CoA to form 3-hydroxy-3-methylglutaryl CoA (HMG-CoA). This molecule is then reduced to mevalonate by the enzyme HMG-CoA reductase. Production of mevalonate is the rate-limiting and irreversible step in cholesterol synthesis and is the site of action for statins. Acetyl-CoA is coming from Citric Acid Cycle. Mevalonate pathway Acetoacetyl-CoA thiolase Acetoacetyl-CoA thiolase hydroxymethylglutaryl-CoA synthase or HMG-CoA synthase; EC 2.3.3.10 1xpk HMG-CoA Reductase HMG-CoA Reductase Mevalonate kinase Mevalonate kinase Phosphomevalonate kinase The Crystal Structure of Human Phosphomavelonate Kinase At 1.8 A Resolution 3ch4 Mevalonate-5-pyrophosphate decarboxylase Diphosphomevalonate decarboxylase (EC 4.1.1.33), most commonly referred to in scientific literature as mevalonate diphosphate decarboxylase. Mevalonate Diphosphate Decarboxylase Isopentenyl pyrophosphate isomerase Isopentenyl pyrophosphate isomerase (EC 5.3.3.2, IPP isomerase), also known as Isopentenyl-diphosphate delta isomerase Isopentenyl-diphosphate delta-isomerase Mevalonate is finally converted to isopentenyl pyrophosphate. Geranyl transferase Three molecules of isopentenyl pyrophosphate condense to form farnesyl pyrophosphate through the action of geranyl transferase. Farnesyl diphosphate synthase

spinqualitylabelsall models Crystal Structure of HMG-CoA, (PDB code 1dq8) Show:Asymmetric Unit Biological Assembly Drag the structure with the mouse to rotate   Export Animated Image